HighVista Strategies »

Rlx Technology shares owned by HighVista Strategies

Quarter-by-quarter ownership of Rlx Technology (RLX) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Rlx Technology

Tip: Access up to 7 years of quarterly data

All positions including Rlx Technology held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rlx Technology by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $686k 312k 2.20

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding Rlx Technology

First Beijing Investment
IDG China Venture Capital Fund V Associates
Vanguard Group
Vanguard Capital Management
Oceanlink Management
D. E. Shaw & Co
BlackRock
Aspex Management
Perseverance Asset Management International
Oasis Management
Barclays
Morgan Stanley
Vanguard Fiduciary Trust
Pictet Asset Management Holding SA
State Street Corporation

View all funds holding Rlx Technology